GlassScriptPhysician profile
Bernard D Bienstock
NPI 1043229008
$359.08
in general payments reported to CMS, 2019-2025
11 companies · $91.25 in 2025
The $91.25 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.37 · 2020: $22.11 · 2021: $12.34 · 2022: $44.42 · 2023: $131 · 2024: $13.34 · 2025: $91.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $204 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $203.57 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $131.25 | 2023 | |
| Allergan, INC. | $44.37 | 2019 | |
| Novo Nordisk INC | $32.27 | 2025 | |
| Abbvie INC. | $24.19 | 2022 | |
| Galderma Laboratories, L.P. | $23.90 | 2025 | Nemluvio |
| Redhill Biopharma INC. | $22.11 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.63 | 2025 | |
| Celgene Corporation | $20.23 | 2022 | |
| Janssen Biotech, INC. | $14.45 | 2025 | Tremfya |
| Micro-Tech Endoscopy USA, INC. | $13.34 | 2024 | Lesionhunter |
| Nestle Healthcare Nutrition INC. | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernard Bienstock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.